Download PDF
Synthesis 2000; 2000(4): 479-495
DOI: 10.1055/s-2000-6357
review
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

The Flourishing Syntheses of Non-Nucleoside Reverse Transcriptase Inhibitors

Ole S. Pedersen* , Erik B. Pedersen
  • *Department of Chemistry, University of Southern Denmark, Odense University, 5230 Odense M, Denmark; Fax +45 66 15 87 80; E-mail: EBP@chem.sdu.dk
Further Information

Publication History

Publication Date:
31 December 2000 (online)

  PDF Download  Permissions and Reprints All articles of this category

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are of increasing importance in the treatment of HIV-1 infected persons. In this review the focus is on the syntheses of the approved NNRTI drugs efavirenz, delavirdine, nevirapine, and their analogues. This review also deals with the syntheses of the most promising NNRTI candidates in clinical testing and with the syntheses of subclasses of NNRTIs with known crystal structures when complexed with the reverse transcriptase enzyme.

efavirenz - sustiva - delavirdine - nevirapine - viramune - rescriptor - HIV